Top Story

Physical activity reduces risk for breast cancer recurrence

February 21, 2017

Exercising is the most important lifestyle change a woman can make to prevent breast cancer recurrence and mortality, according to a systematic review recently published in the Canadian Medical Association Journal.

“Physical activity can reduce breast cancer mortality by about 40%,” Julia Hamer, HBSc, and Ellen Warner, MD, HBSc, division of medical oncology and hematology, Odette Cancer Center, Toronto, wrote. “[It] has the most powerful effect of any lifestyle factor on breast cancer outcomes.”

FDA News

FDA grants priority review to inotuzumab ozogamicin for ALL

February 21, 2017
The FDA granted priority review to inotuzumab ozogamicin for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia, according…
In the Journals PlusPerspective

Alternating treatment fails to delay progression of advanced renal cell carcinoma

February 21, 2017
An 8-week treatment rotation of pazopanib and everolimus failed to improve survival or quality of life in patients with advanced renal cell carcinoma, according to…
Curbside Consultation

Managing Hypoechoic Pancreatic Lesions: Follow-up EUS vs. FNA

Healio Gastroenterology, February 2017
Jason B. Samarasena, MD; Kenneth J. Chang, MD, FACG, FASGE
A: First, it is important to describe what a vague hypoechoic lesion of the pancreas means to an endosonographer (Figure 1). Any lesion that is large, well…

NIH grant to fund research into how lifestyle affects colon cancer outcomes

February 21, 2017
The NIH awarded an $8.8 million grant to Huntsman Cancer Institute at University of Utah to expand research into how lifestyle and other factors affect colon cancer…
More News Headlines »

The Patient with Castration-resistant Prostate Cancer

No commercial support for this activity.

Castration-resistant prostate cancer (CRPC) is a heterogeneous condition that encompasses a continuum of disease…
More »
Meeting News Coverage

VIDEO: Immunotherapy holds potential to eliminate dormant, lethal cancer cells

January 11, 2017
More »

Breakthroughs in the Treatment of Bladder Cancer

This activity is supported by an educational grant from Bristol-Myers Squibb.

Assessment of immune checkpoint blockade inhibitors in the treatment of bladder cancer have demonstrated significant…
More »
Current Issues
View the Current Issue
HemOnc Today